Our 2024 Partners
Applied Biomath
Expertise Partner
Applied BioMath applies biosimulation services and software solutions to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies to help accelerate and de-risk therapeutic research and development. Applied BioMath recently joined Certara in a strategic acquisition to form the life sciences industry's largest team of experts in quantitative systems pharmacology (QSP). Certara’s clients include more than 2,300 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries.
MilliporeSigma
Expertise Partner
MilliporeSigma is the U.S./Canada Life Science business of Merck KGaA, Darmstadt, Germany. We are providing solutions to help advance the promise of life saving therapies. Our integrated Millipore® CTDMO Services combines our expertise in contract development, manufacturing, and testing from pre-clinical to commercial to accelerate your milestones and breakthroughs – with one experienced partner. Millipore® CTDMO Services offer leading expertise in ADC and bioconjugation, including antibody oligonucleotide conjugates and radionucleotides conjugates. We also offer comprehensive support for next-generation small molecule conjugate programs and linker-payload production.
Singzyme
Expertise Partner
Singzyme’s mission is to deliver on the promise of effective mmune-therapies by developing safer and more homogenous, precision medicines for the well-being of patients worldwide. Singzyme applies its platform technology in the field of mmune-therapies with a focus on the conjugation of active molecules to protein carriers, for example, but not limited to Antibody-Drug Conjugates (ADCs).
Abzena
Expertise Partner
We are Abzena. More than a CDMO, we are a responsible and dedicated Partner Research Organization (PRO) that takes care of your products from concept to patient. With extensive experience in developing biologics and bioconjugates, we offer a seamless service delivered by fully integrated teams, from early discovery to commercial manufacturing. Forward-thinking and committed, we find the best solution and use the right technologies to design, develop and manufacture your products to ensure we get vital medicines to patients quickly and safely. We are dedicated to quality excellence. We are driven to get better treatments to market, efficiently and responsibly by reducing timelines and delivering the highest quality products and services.
Montgomery Holdings
Program Partner
Montgomery Holdings is the legacy company for Paul D. Davis, founder and former owner of Quanta BioDesign Ltd., which is now part of Vector Laboratories. Promoting the uniform PEG (the single molecule dPEG® technology) as an integrated technology platform in view of broadening its capabilities in therapeutic and diagnostic applications by taking the existing product portfolio and envisioning their creating the next tiers and generations of conjugates in these key applications using the “The Power of One.” These can be designed to modulate the PK and PD of each new conjugate incorporating the unique and perfectly biocompatible physicochemical properties of the uniform PEG (dPEG®).
BSP Pharmaceuticals
Innovation Partner
BSP Pharmaceuticals S.p. A. is focused on the development and manufacturing of anticancer drugs with high potency and cytotoxic characteristics for the pharmaceuticals industry. BSP has been at the forefront in the fight against cancer since 2006. Innovation is the hallmark of BSP with investments in new technologies and production methods in a high containment plant.
Navigo Proteins
Innovation Partner
Navigo Proteins is a successful and steadily growing, privately held protein engineering company, which develops best-in-class custom precision affinity ligands, based on selected protein scaffolds. We partner with pharma, biotech and life science companies to build innovative biotherapeutics as well as provide next-generation custom affinity solutions for commercial biologics manufacturing based on our proprietary affinity ligands. Our outstanding protein engineering capabilities rely on our dedicated specialist team with in-depth expertise and a strong track record. Our combined know-how is complemented by a state-of-the-art technology toolbox, including robotics-assisted selection and screening technology platforms.
Indena
Exhibition Partner
Headquartered in Italy, Indena is a reliable CDMO/CMO partner for pharma & biotech companies worldwide. We are specialized in challenging chemistry and Highly Potent molecules (OEL down to 20 ng/m3) GMP manufacturing. We have successfully completed 20+ HPAPI projects including payload-linker intermediate thanks to our strong Know-How developed over the years. Would you like to learn more? Meet our team
Target Audience: Companies looking payload-linker intermediate manufacturing partner
ChemGenes Corporation
Exhibition Partner
Established in 1981, ChemGenes has consistently provided the highest quality Phosphoramidites and Solid Supports in the market. Our Massachusetts facility is setup for therapeutic grade phosphoramidites for GMP grade oligonucleotide manufacturing. Furthermore, ChemGenes carries the widest variety of modified phosphoramidites and solid supports currently used in various areas of Nucleic Acid research. ChemGenes remains devoted to providing you with invaluable customer service and comprehensive technical support.
PROVEO
Branding Partner
Formed in 2015, PROVEO is now a Division of Cerbios- Pharma SA focused on complete supply chain solution for Antibody Drug Conjugates (ADCs).Thanks to the partnership with AGC Biologics and Oncotec, PROVEO offer best-in-class solutions for the integrated development and cGMP manufacturing of recombinant proteins (incl mAbs), cytotoxic drug-linker payload, conjugation, aseptic fill and lyophilization. Strengths of the three PROVEO partners secure a seamless and low risk ADC supply chain for clinical and commercial projects.
Goodwin Biotechnology
Branding Partner
Goodwin Biotechnology’s mission is to eliminate the manufacturing risk for companies developing complex biologic therapeutics by being the pre-eminent provider of high-quality, cost-effective, flexible and timely cGMP compliant manufacturing solutions, from pre-clinical development through commercial product supply. By integrating our services in one location, Goodwin provides a Single Source Solution™ to anticipate and overcome the challenges you face with your biopharmaceutical candidate, whether it be complex proteins such as monoclonal antibodies or a sophisticated Antibody Drug Conjugate (ADC).
Curia
Branding Partner
Curia is a Contract Development and Manufacturing Organization with over 30 years of experience, an integrated network of global sites and employees partnering with customers to make treatments broadly accessible to patients. Our biologics offering spans discovery to clinic and fill-finish services across monoclonal antibodies, complex biologics, ADCs, recombinant proteins and mRNA therapeutics. Our scientific and process experts, and state-of-the-art facilities deliver best-in-class experience across drug substance and drug product manufacturing. From curiosity to cure, we deliver every step to accelerate and sustain life-changing therapeutics.